Home > Insider Trading > Filing (0001209191-22-019276)

Filing Details

Accession Number:: 0001209191-22-019276
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-16 17:01:49
Reporting Period:: 2022-03-15

Accepted Time:: 2022-03-16 17:01:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891024	Patterson Companies Inc.	PDCO	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	410886515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1652545	B Les Korsh	1031 Mendota Heights Road St. Paul MN 55120	Vp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-03-15	6,000	$30.91	83,486	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,976	Indirect	By ESOP

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Options	$30.77		2031-07-01	17,339	17,339	Direct
Common Stock	Employee Stock Options	$23.57		2030-07-14	24,780	24,780	Direct
Common Stock	Employee Stock Options	$22.25		2029-07-01	33,784	33,784	Direct
Common Stock	Employee Stock Options	$22.48	2021-07-01	2028-07-01	14,179	14,179	Direct
Common Stock	Employee Stock Options	$47.51	2020-07-01	2027-07-01	11,845	11,845	Direct
Common Stock	Employee Stock Options	$48.47	2019-07-01	2026-07-01	10,379	10,379	Direct
Common Stock	Employee Stock Options	$56.66		2025-07-01	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2031-07-01	17,339	17,339	Direct
2030-07-14	24,780	24,780	Direct
2029-07-01	33,784	33,784	Direct
2028-07-01	14,179	14,179	Direct
2027-07-01	11,845	11,845	Direct
2026-07-01	10,379	10,379	Direct
2025-07-01	25,000	25,000	Direct

Footnotes

The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 8, 2021.
Includes an aggregate of 16,637 RSUs awarded on 7/1/2017, 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Plan. The RSUs vest contingent upon continued employment as follows: 7,938 units vest on 7/1/2022, 2,436 units vest on 7/1/2023, 4,773 units vest on 7/14/2023 and 1,490 units vest on 7/1/2024.
Includes 14,410 RSU equivalents attributable to the July 1, 2020 determination by the Compensation Committee that the performance criteria for the period of April 27, 2019 through April 25, 2020 applicable to non-derivative performance units issued on July 1, 2019 had been satisfied. Subject to continued employment of the Reporting Person through July 1, 2022, the RSU equivalents will automatically convert into shares of common stock.
Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan (ESOP) account through May 21, 2021.
Stock options granted pursuant to the Plan on 7/1/2021.
Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
Stock options granted pursuant to the Plan on 7/14/2020.
Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
Stock options granted pursuant to the Plan on 7/1/2019.
Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
Stock options granted pursuant to the Plan on 7/1/2018.
Stock options granted pursuant to the Plan on 7/1/2017.
Stock options granted pursuant to the Plan on 7/1/2016.
Stock options granted pursuant to the Patterson Companies, Inc. Amended and Restated Equity Incentive Plan on 7/1/2015.
Options are exercisable as follows: 25% on 7/1/2018, 25% on 7/1/2019 and 50% on 7/1/2020.